281 related articles for article (PubMed ID: 19702567)
1. Aptamers as innovative diagnostic and therapeutic agents in the central nervous system.
de Franciscis V; Esposito CL; Catuogno S; Cellai L; Cerchia L
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):393-401. PubMed ID: 19702567
[TBL] [Abstract][Full Text] [Related]
2. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide aptamers for glioma targeting: an update.
Camorani S; Cerchia L
Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
[TBL] [Abstract][Full Text] [Related]
4. Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.
McConnell EM; Holahan MR; DeRosa MC
Nucleic Acid Ther; 2014 Dec; 24(6):388-404. PubMed ID: 25296265
[TBL] [Abstract][Full Text] [Related]
5. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
6. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
[TBL] [Abstract][Full Text] [Related]
8. Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.
Murakami K; Izuo N; Bitan G
J Biol Chem; 2022 Jan; 298(1):101478. PubMed ID: 34896392
[TBL] [Abstract][Full Text] [Related]
9. Aptamers Chemistry: Chemical Modifications and Conjugation Strategies.
Odeh F; Nsairat H; Alshaer W; Ismail MA; Esawi E; Qaqish B; Bawab AA; Ismail SI
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861277
[TBL] [Abstract][Full Text] [Related]
10. Aptamers: selection, modification and application to nervous system diseases.
Yang Y; Ren X; Schluesener HJ; Zhang Z
Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
12. Aptamers: potential applications to pancreatic cancer therapy.
Rialon KL; White RR
Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073
[TBL] [Abstract][Full Text] [Related]
13. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the role of aptamers in the fight against cancer.
Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
[TBL] [Abstract][Full Text] [Related]
15. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
16. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
17. Selection and Application of Aptamers and Intramers.
Avci-Adali M
Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
[TBL] [Abstract][Full Text] [Related]
18. Progress in selection and biomedical applications of aptamers.
Xi Z; Huang R; Deng Y; He N
J Biomed Nanotechnol; 2014 Oct; 10(10):3043-62. PubMed ID: 25992428
[TBL] [Abstract][Full Text] [Related]
19. A Highlight of Recent Advances in Aptamer Technology and Its Application.
Sun H; Zu Y
Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
Reinemann C; Strehlitz B
Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
